GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
Europe - OSL:GENT - NO0010748866 - Common Stock
55 NOK
-0.2 (-0.36%)
Taking everything into account, GENT scores 6 out of 10 in our fundamental rating. GENT was compared to 60 industry peers in the Health Care Equipment & Supplies industry. GENT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. GENT is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
GENT had positive earnings in the past year.
GENT had a positive operating cash flow in the past year.
GENT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
GENT has a Return On Assets of 18.25%. This is amongst the best in the industry. GENT outperforms 95.00% of its industry peers.
GENT has a better Return On Equity (21.37%) than 88.33% of its industry peers.
With a decent Return On Invested Capital value of 7.59%, GENT is doing good in the industry, outperforming 63.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROIC | 7.59% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 25.83%, GENT belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
With a Operating Margin value of 12.10%, GENT perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
GENT has a Gross Margin (54.19%) which is in line with its industry peers.
GENT's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GENT is destroying value.
GENT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for GENT remains at a similar level compared to 5 years ago.
The debt/assets ratio for GENT has been reduced compared to a year ago.
2.2 Solvency
GENT has an Altman-Z score of 16.10. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
GENT has a better Altman-Z score (16.10) than 96.67% of its industry peers.
GENT has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
GENT has a better Debt to FCF ratio (0.33) than 91.67% of its industry peers.
GENT has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of GENT (0.02) is better than 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Altman-Z | 16.1 |
ROIC/WACC0.89
WACC8.51%
2.3 Liquidity
A Current Ratio of 5.47 indicates that GENT has no problem at all paying its short term obligations.
GENT has a Current ratio of 5.47. This is amongst the best in the industry. GENT outperforms 98.33% of its industry peers.
A Quick Ratio of 3.78 indicates that GENT has no problem at all paying its short term obligations.
The Quick ratio of GENT (3.78) is better than 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 2103.43% over the past year.
The Revenue has grown by 11.68% in the past year. This is quite good.
Measured over the past years, GENT shows a very strong growth in Revenue. The Revenue has been growing by 25.96% on average per year.
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
3.2 Future
GENT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.29% yearly.
The Revenue is expected to grow by 31.72% on average over the next years. This is a very strong growth
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.45, GENT is valued on the expensive side.
Based on the Price/Earnings ratio, GENT is valued a bit cheaper than 78.33% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.11. GENT is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 20.27, GENT is valued on the expensive side.
Based on the Price/Forward Earnings ratio, GENT is valued a bit cheaper than the industry average as 65.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.55, GENT is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.45 | ||
| Fwd PE | 20.27 |
4.2 Price Multiples
60.00% of the companies in the same industry are cheaper than GENT, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as GENT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 89.6 | ||
| EV/EBITDA | 26.88 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GENT's earnings are expected to grow with 62.29% in the coming years.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a yearly dividend of 0.70%, GENT is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.13, GENT has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.37, GENT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.7% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
OSL:GENT (11/3/2025, 12:34:35 PM)
55
-0.2 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.83%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap848.10M
Revenue(TTM)163.38M
Net Income(TTM)42.19M
Analysts85.71
Price Target68.34 (24.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.7% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.45 | ||
| Fwd PE | 20.27 | ||
| P/S | 5.19 | ||
| P/FCF | 89.6 | ||
| P/OCF | 42.63 | ||
| P/B | 4.3 | ||
| P/tB | 5.11 | ||
| EV/EBITDA | 26.88 |
EPS(TTM)2.69
EY4.89%
EPS(NY)2.71
Fwd EY4.93%
FCF(TTM)0.61
FCFY1.12%
OCF(TTM)1.29
OCFY2.35%
SpS10.6
BVpS12.81
TBVpS10.76
PEG (NY)0.34
PEG (5Y)N/A
Graham Number27.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROCE | 9.86% | ||
| ROIC | 7.59% | ||
| ROICexc | 12.65% | ||
| ROICexgc | 17.14% | ||
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% | ||
| FCFM | 5.79% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | 115.57% | ||
| Cap/Sales | 6.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 69.08% | ||
| Profit Quality | 22.43% | ||
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 | ||
| Altman-Z | 16.1 |
F-Score5
WACC8.51%
ROIC/WACC0.89
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1114.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y257.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8223.43%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
What is the valuation status of GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?
ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for GENT stock?
The Price/Earnings (PE) ratio for GENTIAN DIAGNOSTICS ASA (GENT.OL) is 20.45 and the Price/Book (PB) ratio is 4.3.